ÂÜŔňÂŇÂ×

Suzanne Craft

Advisor at T3D Therapeutics

Dr. Suzanne Craft received her Ph.D. from the University of Texas at Austin, and then completed fellowships at Boston University and Harvard Medical School. She has been a faculty member at Washington University in St. Louis and at the University of Washington. In 2012, she joined the faculty at Wake Forest School of Medicine, where she is Professor of Internal Medicine, and Founding Director of the National Institute on Aging-funded Alzheimer’s Disease Research Center, one of only 31 national Alzheimer’s Centers of Excellence. She is a member of the Alzheimer’s Association Medical and Scientific Advisory Council, and of the National Alzheimer’s Clinical Trial Consortium.

Dr. Craft investigates the role of metabolic disorders such as insulin resistance in the development of Alzheimer’s disease and has conducted clinical trials of insulin-sensitizing medications, intranasal insulin delivery, and dietary intervention to treat or prevent Alzheimer’s disease. She led a ground-breaking multi-site trial of intranasal insulin for the treatment of Alzheimer’s disease that was funded by the National Alzheimer’s Project Act. An initial pilot study of intranasal insulin was supported by a prestigious Zenith Award from the Alzheimer’s Association. Dr. Craft has also received a National Institute of Health MERIT award for research excellence. Her work has been featured in HBO’s Emmy-award-winning series “The Alzheimer’s Project: Momentum in Science”, in the New York Times and Time magazine, as well as on ABC World News, NBC Nightly News, BBC Newshour, and PBS Newshour.